
December 18, 2020
Factors to Consider When Selecting a Next Generation Sequencing (NGS) Technology
Explore the main factors you need to consider before choosing and using next generation sequencing (NGS).
Our Translational Platforms enable our clients to identify the right patients for the right treatment. Having models which more accurately mimic human disease and population dynamics are key to successfully translating promising compounds into successful clinical candidates, whether treating Oncology or Diabetes related diseases.
Our scientific acumen and experience will give you a deeper understanding of not just the pharmacological profile of your compound, but more importantly, a clear understanding of which compounds to progress into the clinic. Take a look at our publications to get a deeper understanding of the depth of our scientific expertise.
CVMD
CrownBio’s preclinical Translational Technology Platforms provide spontaneous & diet-induced obesity (DIO) models, to support the transition of new agents into the clinic.
Oncology
Our unique databases provide a curated source of well-characterized models available to use for drug discovery including PDX models, cell lines, and syngeneic models.
CVMD
Models of both Type 1 and Type 2 diabetes, including conventional, as well as unique, highly translatable models for in vivo efficacy studies of antidiabetic agents.
December 18, 2020
Explore the main factors you need to consider before choosing and using next generation sequencing (NGS).
December 18, 2020
Explore the main factors you need to consider before choosing and using next generation...
December 16, 2020
Explore the differences and similarities of germ-free (GF) and antibiotic-treated mice as models...
December 3, 2020
Review the status of PARP inhibitors (PARPi) for prostate cancer treatment, with a focus on...
November 30, 2020
Explore why glucocorticoid-induced TNFR-related protein (GITR or CD357) agonists are becoming...
November 10, 2020
Explore why upstream KRAS-mutant targets, such as SHP2 and SOS1, may lead to optimized...
January 26-28, 2021
Virtual